Questões de Inglês Você está resolvendo questões.
Escolha a disciplina, dificuldade em Filtrar Questões
Questão 25 179664FATEC 2018
Technology brought us fake news — and it will help us kill it
“Fake news” - websites disseminating news stories that are false but are believed to be true – was a major feature of the U.S. election season. Some observers believe that it determined the outcome of the election, although there is no way to definitively ascertain its effect on voting.
On the positive side, this means that everyone’s opinion can be disseminated. The awareness of fake news, though, reveals a downside – or perhaps a loophole – of the freedom to post. And fake news may beget1 fake news. Facebook is not the only media company to be an inadvertent host for fake news, but it is by far the largest, with roughly 2 billion users each month.
<https://tinyurl.com/y8jfq2t4> Acesso em: 07.11.2017. Adaptado.
Glossáriobeget1: gerar, criar, produzir.
fallout 2: efeitos negativos.
Assinale a alternativa correta, de acordo com o texto.
Questão 19 181836UEMA 2018
O texto III apresenta 5 dicas para pessoas que buscam um emprego.
5 Best Job Interview Tips for Jobseekers
1. Conduct Research on the Employer, Hiring Manager, and Job Opportunity
Success in a job interview starts with a solid foundation of knowledge on the jobseeker‟s part. You should understand the employer, the requirements of the job, and the background of the person (or people) interviewing you.
2. Thank Interviewer(s) in Person, by Email, or Postal Mail
Common courtesy and politeness go far in interviewing; thus, the importance of thanking each person who interviews you should come as no surprise. Start the process.
3. Review Common Interview Questions and Prepare Your Responses
Another key to interview success is preparing responses to expected interview questions. First, ask the hiring manager as to the type of interview to expect.
4. Remember the Importance of Body Language
While the content of your interview responses is paramount, poor body language can be a distraction at best” or a reason not to hire you at worst. Effective forms of body language include smiling, eye contact, solid posture, active listening, and nodding.
5. Dress for Success
Plan out a wardrobe that fits the organization and its culture, striving for the most professional appearance you can accomplish.
Disponível em: www. livecareer.com (Adapted)
O texto III apresenta cinco “dicas” para uma boa entrevista de emprego. A “dica” que se refere ao vestuário é encontrada no item
Questão 60 191517IMEPAC 2018
FDA approves new drug to treat type of liver cancer
Hepatocellular carcinoma is the most common form of liver cancer, accounting for three-quarters of liver cancers in the United States and is the second leading cause of cancer-related deaths worldwide.
By Amy Wallace | May 4, 2017 at 4:48 PM
May 4 (UPI) – The U.S. Food & Drug Administration Thursday approved a new drug to treat the most common form of liver cancer, hepatocellular carcinoma.
The drug, regorafenib, is the first and only treatment approved by the FDA in more than a decade to show significant improvement in patients with hepatocellular carcinoma, or HCC.
HCC accounts for three-quarters of liver cancers in the United States and is the second leading cause of cancer related deaths worldwide. Roughly 40,000 Americans will be diagnosed with liver cancer in 2017 with more than 28,000 dying from the disease.
Doctors were only able to treat the early and intermediate stages of the disease in the affected area of the liver with surgery, transplantation or chemotherapy. But when the cancer progresses, patients are often candidates for systemic therapies.
Sorafenib was initially approved by the FDA 10 years ago as the first systemic therapy for patients with advanced HCC. The new approval by the FDA allows for another option for patients whose cancer progressed after traditional and systemic treatments.
Researchers at UCLA and 21 other sites in the United States, Europe and Asia tested the drug on 567 people with HCC in a two-year Phase III clinical trial called RESORCE.
Regorafenib was shown to extend overall survival by 10.6 months compared to 7.8 months for patients receiving a placebo, resulting in an average improvement in survival of 3.1 months and a 37 percent reduction in the risk of death in patients with HCC.
"When liver cancer progresses to advanced stages, a cure is no longer possible,” Dr. Richard Finn, associate professor of medicine at the David Geffen School of Medicine and director of the Signal Transduction and Therapeutics Program at UCLA’s Jonsson Comprehensive Cancer Center, said in a press release. “Traditional treatments can help slow and control the disease for a short period of time, but eventually tumor growth will continue. Today’s approval of regorafenib is a major clinical advancement for patients when initial therapies are no longer working.”
Available at: . Accessed on: September 4th, 2017 (Adapted).
Professor Richard Finn declared in a press release that the approval of regorafenib